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Abstract  
Patellofemoral pain is common amongst recreational runners and associated with 
altered running kinematics. However, it is currently unclear how sex may influence 
kinematic differences previously reported in runners with patellofemoral pain. This 
case-control study aimed to evaluate lower limb kinematics in males and females 
with and without patellofemoral pain during running. Lower limb 3D kinematics 
were assessed in 20 runners with patellofemoral pain (11 females, 9 males) and 20 
asymptomatic runners (11 females, 9 males) during a 3km treadmill run. Variables of 
interest included peak hip adduction, internal rotation and flexion angles; and peak 
knee flexion angle, given their previously reported association with patellofemoral 
pain. Age, height, mass, weekly run distance and step rate were not significantly 
different between groups. Mixed-sex runners with patellofemoral pain were found 
to run with a significantly greater peak hip adduction angle 
d=0.91, 95% CI 1.4-8.2, p=0.01) when compared to matched controls, but analyses 
for all other kinematic variables were non-significant. Females with patellofemoral 
pain ran with a significantly greater peak hip adduction angle compared to female 
p=0.02, F=3.41, 95% CI 0.4-12.8). Analyses for all 
other kinematic variables between groups (males and females with/without PFP) 
were non-significant. Differences in peak hip adduction between those with and 
without patellofemoral pain during running appear to be driven by females. This 
potentially highlights different kinematic treatment targets between males and 
females. Future research is encouraged to report lower limb kinematic variables in 
runners with patellofemoral pain separately for males and females.  
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1.0 Introduction 1 
Patellofemoral pain (PFP) is described as either retropatellar or peripatellar pain of 2 
atraumatic onset, associated with knee joint loading into flexion. (Crossley et al., 3 
2016) Running is a common aggravating factor, with incidence reported to range 4 
from as low as 4% throughout a two year period, (Noehren et al., 2013) to as high as 5 
(Thijs et al., 2011) A recent 6 
systematic review and meta-analysis identified no risk factors from pooled 7 
prospective data for the development of PFP in a recreational running population. 8 
(Neal et al., 2018a) 9 
 10 
Whilst there is a paucity of prospective research investigating risk factors for PFP in 11 
running populations, female recreational runners have been reported to be at an 12 
increased risk of developing PFP in the presence of a high peak hip adduction angle. 13 
(Noehren et al., 2013) Additionally, runners with persistent PFP have been reported 14 
to run with increased peak hip adduction and internal rotation angles compared to 15 
asymptomatic controls. (Fox et al., 2018; Noehren et al., 2012a; Noehren et al., 16 
2012b; Willy et al., 2012a) Whilst there are literature to the contrary, (Dierks et al., 17 
2011; Esculier et al., 2015), a recent meta-analysis identified moderate to strong 18 
cross-sectional associations between PFP and altered pelvic and hip kinematics when 19 
all available data are pooled. (Neal et al., 2016) It is thought that these kinematic 20 
variations may contribute to the development and persistence of PFP by way of 21 
increasing patellofemoral joint stress, and thus provide treatment targets when 22 
using interventions such as gait retraining. (Noehren et al., 2011; Willy et al., 2012b)   23 
 24 
 2 
Recreational runners with PFP have been reported to demonstrate a reduced stance 25 
phase hip flexion angle when compared to matched controls. (Bazett-Jones et al., 26 
2013) In addition, an increased peak knee flexion angle has been reported to 27 
increase patellofemoral joint stress, (Lenhart et al., 2014) with a reduced peak knee 28 
flexion angle also correlating positively with symptom reduction after step-rate 29 
retraining. (Neal et al., 2018b) As these sagittal plane variables are associated with 30 
PFP persistence and may present potential treatment targets, their further 31 
investigation was warranted given the lower volume of work to date in comparison 32 
to variables in the frontal and transverse planes.      33 
 34 
A higher prevalence of PFP is reported amongst females. (Boling et al., 2010) 35 
However, despite the breadth of literature evaluating the kinematics of runners with 36 
PFP, current understanding of the influence of sex on running kinematics in those 37 
with PFP is poor. Multiple studies have evaluated only females with PFP, (Noehren et 38 
al., 2012a; Noehren et al., 2012b) while others have evaluated mixed-sex PFP 39 
cohorts with no sub-analysis of the individual sexes. (Bazett-Jones et al., 2013; Dierks 40 
et al., 2008; Esculier et al., 2015) This is problematic, as asymptomatic females are 41 
reported to demonstrate different kinematic (Chumanov et al., 2008) and kinetic 42 
(Sinclair and Selfe, 2015) profiles during running in comparison to males. 43 
  44 
One previous study evaluated kinematic differences between males and females 45 
with PFP during running, (Willy et al., 2012a) reporting that females with PFP 46 
demonstrate a greater peak hip adduction angle compared to both males with PFP 47 
and male controls. In contrast, males with PFP were reported to run with a greater 48 
 3 
peak knee adduction angle when compared to both females with PFP and male 49 
controls. Limitations of this study include use of a fixed speed (3.35m/sec), which 50 
may result in different findings to when running at a self-selected speed (Schache et 51 
al., 2011; Vincent et al., 2014); and the lack of a female control group. Improving 52 
understanding of how kinematic associations with PFP may differ between sexes is 53 
important to guide the development of more tailored interventions for this often 54 
persistent condition. (Lankhorst et al., 2016) 55 
 56 
This case-control study aimed to evaluate treadmill-running kinematics at self-57 
selected speeds in a mixed sex cohort of runners with and without PFP. A secondary 58 
aim was to further analyse kinematic data when these cohorts were divided into 59 
males and females with and without PFP, to investigate potential kinematic 60 
differences between the sexes. It was hypothesised that runners with PFP would 61 
demonstrate an increased peak hip adduction angle in comparison to matched 62 
controls, with greater increases observed amongst females with PFP.   63 
 4 
2.0 METHODS 64 
2.1 Participants  65 
The Queen Mary Ethics of Research Committee granted ethical approval for this 66 
study (QMREC2014/63) and all participants provided written informed consent prior 67 
to participation. A convenience sample of participants with and without PFP was 68 
sought from local sports medicine clinics and running clubs respectively.  69 
 70 
An a priori sample size calculation for one-way, fixed-effects ANOVA was conducted, 71 
with peak hip adduction angle as the primary dependent variable. Using data from 72 
previous work, (males with PFP , male 73 
), (Willy et al., 2012a) five participants were required to 74 
determine the difference between these three groups, achieving  and , 75 
with an effect size (f) of 3.2 (calculated using G*Power 3.1.9.3, Heinrich-Heine 76 
University, Germany). We therefore recruited 20 participants per group defined 77 
either by sex or presence of PFP, allowing for five participants per dependent 78 
variable to be investigated.    79 
 80 
20 runners with PFP (11 females, 9 males) and 20 asymptomatic runners (11 81 
females, 9 males) were recruited (see table 1). To be included in the PFP group, 82 
participants were required to have retropatellar or peripatellar pain for at least the 83 
past three months, with their worst pain (most significant) rated at a minimum of 84 
three (out of a maximum of 10) using a numerical rating scale (NRS). An average pain 85 
(day to day) score using the NRS was also recorded. Symptoms were required to be 86 
present during running and one other activity described by the most recent PFP 87 
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consensus document. (Crossley et al., 2016) Participants with patellofemoral 88 
instability, tibiofemoral pathology or previous lower limb surgery were excluded. To 89 
be included in the control group, participants were required to be free of running-90 
related injury for a minimum of three months and have no previous history of PFP. 91 
All participants were of either sex, currently or recently running a minimum of 10 92 
km/week and aged between 18 and 45 years.  93 
 94 
Table 1 95 
Participant characteristics 96 
Variable  Male PFP  
Mean (SD) 
Male Control 
Mean (SD) 
Female PFP  
Mean (SD) 
Female Control 
Mean (SD) 
Age (Years) 31.8 (7.6) 28.7 (4.4) 29.4 (4.3) 32.4 (4.7) 
Height (cm) 179.8 (5.3) 177.5 (6.8) 153.9 (6.4) 167.1 (4.8) 
Mass (kg) 74.2 (7.9) 73.2 (11.9) 56.8 (5.8) 59.5 (6.3) 
Average run volume  
(km) 
18.1 (7.3) 15.8 (9.7) 16.3 (10.5) 23.0 (13.0) 
Step rate (SPM) 164.2 (7.3) 166.7 (8.7) 151.2 (3.9) 167.5 (6.5) 
Symptom duration 
(Months) 
73.3 (66.2) N/A 37.9 (3.2) N/A 
Kujala scale  89.2 (5.1) N/A 79.1 (7.9) N/A 
Average NRS  3.0 (1.8) N/A 3.2 (1.3) N/A 
Worst NRS  7.0 (1.8) N/A 6.0 (1.1) N/A 
Key: SD=standard deviation; SPM=steps per minute; NRS=numerical rating scale; 97 
N/A=not applicable.  98 
 99 
2.2 Experimental Protocol 100 
 6 
Participants were required to present to the Human Performance Laboratory at 101 
Queen Mary University of London. Data pertaining to one limb, rather than two, was 102 
entered into the analysis to reduce type I error potential. (Menz, 2005) For 103 
participants with bilateral symptoms, the limb that rated the highest on the worst 104 
pain numerical rating scale was included. For participants with equivalent symptoms, 105 
or for the control participants, the dominant limb (defined as the limb that would be 106 
used to kick a ball) was included. (Willy et al., 2012b) Participants in the PFP group 107 
also completed the Kujala Scale, (Kujala et al., 1993) a 13-question appraisal of 108 
subjective function in those with PFP, with a score of 100 representing no symptoms 109 
and a score of zero indicating complete disability. 110 
 111 
2.3 Kinematic Measures  112 
Kinematic data were collected during running using a four-camera, infrared motion 113 
analysis system (CX-1, Codamotion, Charnwood Dynamics Limited, Leicestershire, 114 
UK). (Lack et al., 2014) 24 infrared markers, consisting of eight individual markers 115 
and four rigid clusters of four markers, were placed on standard pelvic and lower 116 
limb anatomical landmarks using the CAST protocol by the primary investigator (BN). 117 
(Cappello et al., 1997) Unpublished laboratory data for the primary investigator (BN) 118 
have previously identified moderate to excellent intra-rater reliability (ICC 0.62  119 
0.93), with respect to positioning of kinematic markers in three-dimensional space. 120 
Rigid clusters were applied using adjustable elastic straps and were secured with 121 
cohesive self-adherent bandage and individual markers were applied using double-122 
sided adhesive tape and secured with transparent surgical tape. Virtual markers 123 
were also identified on the femoral epicondyles and the ankle malleoli, to allow for 124 
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the calculation of relevant joint centers during an upright standing trial. The knee 125 
joint centre was estimated as the mid-point between the femoral epicondyle 126 
markers and   the hip joint centre was estimated as a projection within the pelvis 127 
frame using previously described methods. (Bell et al., 1990) Joint centre calculation 128 
did not differ between male and female participants.  129 
 130 
Participants were required to run in their usual running shoes and at their typical 131 
(Kistler Gaitway, Kistler 132 
Group, Winterthur, Switzerland). Participants were given approximately six minutes 133 
to acclimate their running gait to the treadmill condition, previously reported to 134 
(Lavcanska et al., 135 
2005). Participants ran for a total of three kilometers (km), with 10 seconds of data 136 
sampled at 200Hz collected at 0.8/1.8/2.8km. Distance, as opposed to time, was 137 
chosen to act as a constant measure across a cohort of participants running at 138 
different speeds.  139 
 140 
To increase the reliability of gait analysis, multiple data collections were completed. 141 
(Monaghan et al., 2007) Specifically, a peak kinematic outcome for all dependent 142 
variables was determined for each individual stance phase, with an average then 143 
determined for each 10 seconds of data collection, subsequently mean pooled 144 
across the three individual data collections described above. (Neal et al., 2018b) 145 
Participants in the PFP group were given the option to cease data collection if their 146 
symptoms increased to four or greater on the NRS. Variables of interest included 147 
peak hip adduction, internal rotation and flexion angles and peak knee flexion angle, 148 
 8 
based on between group differences (PFP compared to control) identified in our 149 
recent meta-analysis. (Neal et al., 2016) 150 
 151 
2.4 Data Analysis  152 
Data were analysed offline using a customised Matlab program (version 2015, 153 
Mathworks, Natick, Massachussets, USA). Initial foot contact and toe off were 154 
identified using the calcaneal tuberosity marker and the metatarsal head marker in 155 
the vertical (Z) axis. Consistent with previously described methods, initial foot 156 
contact was defined as the point at which the calcaneal tuberosity marker ceased its 157 
descent in the vertical axis. (Fellin et al., 2010; Zeni et al., 2008) Toe off was 158 
identified by determining peak acceleration of the fifth metatarsal marker relative to 159 
the calcaneal tuberosity marker. (Fellin et al., 2010; Schache et al., 2001) These 160 
methods have previously been reported to have low absolute errors. (Fellin et al., 161 
2010) All kinematic data were aligned to initial foot contact, interpolated and 162 
normalised to percentage of stride cycle (0% = initial contact, 100% = terminal 163 
stance).  164 
 165 
2.5 Statistical Analysis  166 
All statistical testing were performed offline using SPSS (version 22 for MacOS, IBM, 167 
New York, USA). Two-tailed, independent samples t-tests were used to determine 168 
statistical differences between pairs of groups (PFP versus control). One-way analysis 169 
of variance (ANOVA) with four sub-groups defined by sex and symptoms was 170 
conducted, -hoc test, which does not require statistical correction 171 
for multiple comparisons. Statistical significance of data was set   0.05, with a 172 
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trend defined as  d was also calculated to determine the effect size 173 
of all identified inter-group differences, alongside the reporting of mean differences 174 
and 95% confidence intervals (CI). d was interpreted as small (< 0.2), 175 
medium (>0.5) and large (>0.8) respectively. (Sullivan and Feinn, 2012). Greatest 176 
individual absolute between day difference (GBDD) data (without a marker 177 
placement device) from previous work (Noehren et al., 2010) were used to 178 
determine the clinical relevance of identified kinematic differences.  179 
 10 
3.0 RESULTS 180 
3.1 Participant characteristics  181 
Analyses of all characteristics between groups were non-significant and are detailed 182 
in table 1 (P=0.23-0.59). Participants in the PFP group demonstrated a prolonged 183 
duration of pain (55.8 [±51.6] months), but only a mild impairment in function, 184 
reflected by a mean Kujala scale score of 87.6 (±6.8).  185 
 186 
3.2 PFP versus control (mixed-sex)  187 
The mixed-sex PFP cohort ran with a significantly greater peak hip adduction angle 188 
P=0.01, d=0.91, 95% CI 1.4-8.2) when compared to the 189 
control group (see figure 1). No significant differences were identified for any other 190 
variable (see Table 2). 191 
 192 
Table 2 193 
Comparison between participants with PFP and matched controls  194 
Variable PFP  
Mean (SD) 
Controls 
Mean (SD) 
Mean 
Difference  
P d 95% CI 
KFLEX    0.54 0.19 -2.5 to 4.7 
HFLEX    0.38 0.28 -2.8 to 7.2 
HADD   (+) 0.01* 0.92 1.4 to 8.2 
HIR    0.37 0.28 -2.6 to 6.8 
Key: SD=standard deviation; KFLEX=peak knee flexion; HFLEX=peak hip flexion; 195 
HADD=peak hip adduction; HIR=peak hip internal rotation; CI=confidence interval; 196 
*=indicates significance; (+) mean difference exceeds GBDD.  197 
 198 
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Figure 1 199 
Graph depicting pooled mean hip adduction for all four groups during running stance 200 
phase. Solid and dashed error bars reflect 95% confidence intervals for female and 201 
male control subjects respectively.   202 
 203 
3.2 Sub-group analysis 204 
Females with PFP ran with a significantly greater peak hip adduction angle compared 205 
to female controls (mean difference=6.6 P=0.02, F=3.41, 95% CI 0.4 to 12.8), with a 206 
trend towards female runners having a significantly greater peak hip adduction angle 207 
when compared to male controls (mean difference=6.3 P=0.06, F=3.41, 95% CI -0.3 208 
to 12.8) (see figure 1). No significant differences were identified for any other 209 
variable. Full details can be found in table 3. 210 
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4.0 DISCUSSION 215 
Our findings indicate a greater peak hip adduction angle during running in the PFP 216 
group, compared to matched controls when mixed sex comparisons are made. 217 
However, this difference appears to be influenced by participant sex, with a greater 218 
peak hip adduction angle observed in female runners with PFP compared to female 219 
controls, but with no differences identified between males with and without PFP.   220 
 221 
4.1 Frontal plane hip kinematics  222 
Findings of a greater peak hip adduction angle in this mixed-sex cohort of runners 223 
with PFP compared to matched controls are consistent with Fox et al, who recently 224 
reported greater frontal plane hip motion during running in their chronic PFP cohort. 225 
(Fox et al., 2018) However, they conflict with other mixed-sex studies, (Bazett-Jones 226 
et al., 2013; Dierks et al., 2011; Esculier et al., 2015) which reported no differences in 227 
peak hip adduction angle when comparing runners with PFP to asymptomatic 228 
runners.  229 
 230 
Fox et al did not report a difference in peak hip adduction angle for their acute PFP 231 
cohort (defined as the presence of PFP for less than one month), compared to 232 
matched controls. (Fox et al., 2018) As Dierks et al and Bazett-Jones et al used similar 233 
inclusion criteria (minimum symptom duration one to two months) (Bazett-Jones et 234 
al., 2013; Dierks et al., 2011) and did not report on symptom duration, it could be 235 
that symptom duration explains the conflicting kinematic outcomes. However, 236 
Esculier et al included participants with more prolonged PFP symptoms (mean 237 
duration 38.1 [±45.5] months), (Esculier et al., 2015), which is comparable to the 238 
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symptom duration observed in participants from this study (mean duration 55.8 239 
[±51.6] months) and Fox et al (mean duration 32.2 [±35.5] months). (Fox et al., 2018) 240 
It is therefore more likely that this conflict can simply be explained by the accepted 241 
heterogeneity of PFP as a condition. (Powers et al., 2017)  242 
 243 
4.1.1 Frontal plane hip kinematics: the influence of sex  244 
Our findings indicate a greater peak hip adduction angle in females with PFP 245 
compared to female controls. These data are in agreement with the three previous 246 
case-control studies comparing females with PFP to female controls, (Noehren et al., 247 
2012a; Noehren et al., 2012b; Willson and Davis, 2008) all of which reported a higher 248 
peak hip adduction angle during running in the PFP cohorts.  249 
 250 
Esculier et al reported no differences in peak hip adduction angle between groups 251 
for their mixed-sex comparison. (Esculier et al., 2015) They did however report a 252 
significant difference in peak hip adduction angle between participants with and 253 
without PFP when performing a sub-analysis for female participants at the toe-off 254 
phase of gait (mean difference . (Esculier et al., 2015) This is consistent with the 255 
findings of our study and given the large mean differences in peak hip adduction 256 
angle between females with PFP and both male  controls, it is 257 
suggested that these female PFP data may be resulting in the significant difference 258 
for the pooled mixed-sex outcome.   259 
 260 
Consistent with our findings, Willy et al reported that females with PFP ran with a 261 
greater peak hip adduction angle compared to male controls. (Willy et al., 2012a) 262 
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However, contrary to our findings, they also reported that their female PFP cohort 263 
ran with a significantly greater hip adduction angle compared with their male PFP 264 
cohort. As the mean difference from our data is above the GBDD for hip adduction 265 
, (Noehren et 266 
al., 2010) it is likely that our smaller sample size (n=11 compared to n=18) accounts 267 
for the lack of statistical significance in our findings. Considering sex specific 268 
differences identified in our current, and previous studies, future studies evaluating 269 
running kinematics are advised to report data for males and females separately, 270 
irrespective of study design.  271 
 272 
4.2 Sagittal plane kinematics  273 
A previous mixed-sex study reported a significantly lower peak hip flexion angle in 274 
runners with PFP  compared to controls ( , (Bazett-Jones et al., 2013) 275 
which was not observed in this mixed-sex cohort. However, whilst not statistically 276 
significant, a lower peak hip flexion angle was observed in female runners with PFP 277 
, compared to male runners with PFP . Bazett-Jones et al 278 
hypothesized that an increase in peak hip flexion angle may be an attempt to 279 
compensate for weakness of the hip extensor muscles, (Bazett-Jones et al., 2013) 280 
which have a mechanical advantage in positions of greater hip flexion. However, 281 
there is a greater breadth of literature reporting lower isometric hip extensor 282 
strength in females with PFP (Rathleff et al., 2014) and muscle strength and running 283 
kinematics have been previously reported to not be associated, (Hannigan et al., 284 
2017) bringing this hypothesis into question. Future studies are encouraged to 285 
further investigate the influence of sagittal plane hip kinematics on PFP.    286 
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 287 
Despite previous studies reporting that peak knee flexion angle correlates positively 288 
with patellofemoral joint stress (increased flexion=increased stress), no increase in 289 
peak knee flexion angle was observed in our PFP group. This is in agreement with the 290 
previous study of Wirtz et al, who reported no increases in patellofemoral joint 291 
stress when comparing female runners to match controls. (Wirtz et al., 2012) 292 
Individuals with PFP have previously been reported to perform stair ambulation with 293 
reduced knee flexion, thought to be in attempt to control pain by mediating 294 
patellofemoral joint stress (Crossley et al., 2004). The increased peak hip flexion 295 
angle observed in the males with PFP in this study may reflect kinesophobia 296 
(a reluctance to or fear of flexing the knee joint), a phenomenon previously 297 
observed in individuals with PFP (de Oliveira Silva et al., 2019), though it is 298 
unclear why such an adaptation would not be observed in the female group. Further 299 
investigation of sagittal plane hip and knee mechanics and their influence on PFP 300 
during running is encouraged.      301 
 302 
4.3 Individual kinematic responses  303 
Some participants from both sexes do demonstrate individual kinematic patterns 304 
that are in contrast to the mean pooled data (see figure 2). In the male subgroup, 305 
there were two PFP participants with a peak hip adduction angle below the pooled 306 
307 
with a peak hip adduction angle above the pooled mean of the PFP group (308 
espectively). However, in the female subgroup, there were no PFP 309 
participants with a peak hip adduction angle below the pooled mean of the control 310 
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group and three control participants with a peak hip adduction angle above the 311 
pooled mean of the PFP group (  respectively). Whilst this 312 
further confirms an association between an increased peak hip adduction angle 313 
during running and PFP, especially in females, such an increase was not observed in 314 
all participants.  315 
Figure 2 316 
Individual peak hip adduction data points for participants with and without PFP, with 317 
each sex presented individually. The dotted line represents the pooled mean of the 318 
PFP group and the dashed line represents the pooled mean of the control group 319 
(CON).  320 
 321 
4.4 Kinematic treatment targets  322 
In previous observational case series, gait-retraining interventions to reduce peak 323 
hip adduction angle during running have been reported to reduce pain and improve 324 
function in females with PFP. (Noehren et al., 2011; Willy et al., 2012b) The mean 325 
reduction in peak hip adduction angle from these studies was , comparable to the 326 
magnitude of difference between the females with PFP and the female controls 327 
 in this study. When considered alongside the fact that an increased peak hip 328 
adduction angle was not associated with PFP in male runners in these and other 329 
studies data, (Willy et al., 2012a) it is suggested that gait-retraining interventions to 330 
reduce peak hip adduction angle may only applicable to female runners with PFP. 331 
However, an absence of benefit in males with PFP would need to be observed 332 
through further research to confirm this.  333 
 334 
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4.5 Limitations and future directions 335 
Findings from this study should be interpreted within the context of its limitations. 336 
The retrospective, case-control design does not allow for the interpretation of 337 
causality and it may be that the observed kinematics are simply adaptations to 338 
persistent pain rather than the primary driver of symptoms. (Lack et al., 2018) Whilst 339 
there are some data to support the notion that altered hip kinematics may increase 340 
the risk of future PFP development in female runners, (Noehren et al., 2013) there 341 
remains a dearth of prospective literature. Further research is needed to determine 342 
if males and females might have different running kinematic risk profiles for the 343 
development of PFP.  344 
 345 
Treadmill running gait, which was evaluated in this study, may not fully reflect 346 
kinematics of over ground running. However, it has been reported that hip and knee 347 
kinematics, (Fellin et al., 2010) as well as peak and rate of patellofemoral joint stress 348 
(Willy et al., 2016) are not significantly different when comparing treadmill with over 349 
ground running in asymptomatic populations. As participants were also given 350 
approximately six minutes to acclimate their running gait to the treadmill condition, 351 
(Lavcanska et al., 2005) appropriate steps have been taken to ensure that the 352 
reported results are representative of a parti  353 
 354 
Kinematic data were collected at specific points during a 3km run before 355 
subsequently being pooled. There is therefore the potential for fatigue to have 356 
influenced the kinematic outcomes in this study, which we attempted to mitigate 357 
this potential by instructing participants to self-select their o358 
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running speed. This should have prevented participants from reaching the levels of 359 
fatigue previously reported to significantly alter running kinematics, (Bazett-Jones et 360 
al., 2013; Dierks et al., 2011) though we did not apply any metric to measure any 361 
potential fatigue.                 362 
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5.0 CONCLUSION 363 
Our findings indicate runners with PFP have a significantly greater peak hip 364 
adduction angle when compared to matched controls. This finding appears to be 365 
influenced by sex, as females, but not males, were found to have a significantly 366 
greater peak hip adduction angle when compared to sex matched controls. These 367 
differences between sexes in kinematic profiles may highlight the need for different 368 
treatment targets in males and females. Future research is encouraged to report 369 
lower limb kinematic variables in runners with PFP separately for males and females.  370 
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Figure 1 
Graph depicting pooled mean hip adduction for all four groups during running stance 
phase. Solid and dashed error bars reflect 95% confidence intervals for female and 
male control subjects respectively.   
Figure 2 
Individual peak hip adduction data points for participants with and without PFP, with 
each sex presented individually. The dotted line represents the pooled mean of the 
PFP group and the dashed line represents the pooled mean of the control group 
(CON).  
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